Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03800056

Characterization of the Fungal Origins in the Autoimmune Polyendocrinopathy of Type 1 Compared With the Autoimmune Polyendocrinopathies of Type 2

Status
Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
85 Years
Healthy volunteers
Not accepted

Summary

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) is an autosomal recessive disease caused by mutations in the autoimmune regulator (AIRE) gene, characterized by the clinical triad of chronic mucocutaneous candidiasis (CMC), hypoparathyroidism, and adrenal insufficiency. CMC can be complicated by systemic candidiasis or oral squamous cell carcinomas (SCCs) and may lead to death. The role of chronic Candida infection in the etiopathogenesis of oral SCC is unclear. Long term use of fluconazole lead to emergence of C. albicans strains with azoles decreased susceptibility. CMC is associated with an impaired Th17 cell response, however, it remains unclear whether decreased serum IL-17 and IL-22 levels are related to a defect in cytokine production or to neutralizing autoantibodies resulting from mutations in the AIRE gene

Conditions

Timeline

Start date
2021-04-23
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2019-01-10
Last updated
2022-02-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03800056. Inclusion in this directory is not an endorsement.